Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Bacterial growth on the skin surface refers to the colonization and proliferation of bacteria on the outermost layer of human skin. The skin acts as a physical and chemical barrier, but it is naturally inhabited by a diverse community of microorganisms, including bacteria. Most are harmless or beneficial (commensals), but under certain conditions, pathogenic bacteria can overgrow or invade deeper tissues, leading to infection. Key species include Staphylococcus epidermidis, Staphylococcus aureus, Streptococcus pyogenes, and Cutibacterium acnes. The resident microbiota competes with potential pathogens. Disruption of the skin barrier or immune suppression allows opportunistic pathogens to invade deeper layers and cause infection.
Antibacterial agents inhibit bacterial growth, disrupt cell wall synthesis, or interfere with bacterial metabolic processes.
2 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Bacterial Growth on Skin Surface.